HUGO LOPEZ: Open Payments
NPI 1497193817 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 18 payments from 9 companies in 2025. Trend: 2023 $2,720 · 2024 $1,296 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $187 |
| Amgen Inc. | 4 | $171 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Novo Nordisk Inc | 2 | $34 |
| Lilly USA, LLC | 1 | $22 |
| Lundbeck LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Kerendia, REPATHA, LifeVest, CAPLYTA, Wegovy, OTEZLA, MOUNJARO, REXULTI.
Industry payments across TX — which companies pay providers there.
